Network-based transfer of pan-cancer immunotherapy responses to guide breast cancer prognosis
Abstract Breast cancer prognosis is complicated by tumor heterogeneity. Traditional methods focus on cancer-specific gene signatures, but cross-cancer strategies that provide deeper insights into tumor homogeneity are rarely used. Immunotherapy, particularly immune checkpoint inhibitors, results fro...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Nature Portfolio
2025-01-01
|
| سلاسل: | npj Systems Biology and Applications |
| الوصول للمادة أونلاين: | https://doi.org/10.1038/s41540-024-00486-7 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
